Stress, depression and cardiovascular dysregulation: A review of neurobiological mechanisms and the integration of research from preclinical disease models

References

• Adell A, Garcia-Marquez C, Armario A, Gelpi E. Chronic stress increases serotonin and noradrenaline in rat brain and sensitizes their responses to a further acute stress. J Neurochem 1988; 50: 1678–1681
   PubMed Web of Science ®Google Scholar
• Adis International Limited. Etanercept: Soluble tumour necrosis factor receptor, TNF receptor fusion protein, TNFR-Fc, TNR 001, Enbrel®. Drugs R&D 1999; 1: 258–261
   PubMedGoogle Scholar
• Advanstar Communications. Top 200 brand-name drugs by retail dollars in 2006. Drug Topics 2007a; 151, http://www.drugtopics.com/drugtopics/data/articlestandard/drugtopics/072007-405100/article.pdf
   Google Scholar
• Advanstar Communications. Top 200 generic drugs by retail dollars in 2006. Drug Topics 2007b; 151, http://www.drugtopics.com/drugtopics/data/articlestandard/drugtopics/072007-405102/article.pdf
   Google Scholar
• Airaksinen KE. Autonomic mechanisms and sudden death after abrupt coronary occlusion. Ann Med 1999; 31: 240–245
   PubMed Web of Science ®Google Scholar
• American Psychiatric Association. Diagnostic and statistical manual of mental disorders, fourth edition, text revision. American Psychiatric Association, Washington, DC 2000
   Google Scholar
• American Psychological Association. For a healthy mind and body…talk to a psychologist. American Psychological Association, Washington, DC 2004
   Google Scholar
• Anda R, Williamson D, Jones D, Macera C, Eaker E, Glassman A, Marks J. Depressed affect, hopelessness, and the risk of ischemic heart disease in a cohort of U.S. adults. Epidemiology 1993; 4: 285–294
   PubMed Web of Science ®Google Scholar
• Anisman H, Zacharko RM. Depression: The predisposing influence of stress. Behav Brain Sci 1982; 5: 89–137
   Web of Science ®Google Scholar
• Anisman H, Zacharko RM. Multiple neurochemical and behavioral consequences of stressors: Implications for depression. Pharmacol Ther 1990; 46: 119–136
   PubMed Web of Science ®Google Scholar
• Anisman H, Zacharko RM. Depression as a consequence of inadequate neurochemical adaptation in response to stressors. Br J Psychiatry 160 1992; 15(Suppl. 15)36–43
   Google Scholar
• Appels A, Mulder P. Excess fatigue as a precursor of myocardial infarction. Eur Heart J 1988; 9: 758–764
   PubMed Web of Science ®Google Scholar
• Asnis GM, Halbreich U, Ryan ND, Rabinowicz H, Puig-Antich J, Nelson B, Novacenko H, Friedman JH. The relationship of the dexamethasone suppression test (1 mg and 2 mg) to basal plasma cortisol levels in endogenous depression. Psychoneuroendocrinology 1987; 12: 295–301
   PubMed Web of Science ®Google Scholar
• Azpíroz A, Fano E, Garmendia L, Arregi A, Cacho R, Beitia G, Brain PF. Effects of chronic mild stress (CMS) and imipramine administration, on spleen mononuclear cell proliferation response, serum corticosterone level and brain norepinephrine content in male mice. Psychoneuroendocrinology 1999; 24: 345–361
   PubMed Web of Science ®Google Scholar
• Badoer E. Hypothalamic paraventricular nucleus and cardiovascular regulation. Clin Exp Pharmacol Physiol 2001; 28: 95–99
   PubMed Web of Science ®Google Scholar
• Bagdy G, Makara GB. Hypothalamic paraventricular nucleus lesions differentially affect serotonin-1A (5-HT1A) and 5-HT2 receptor agonist-induced oxytocin, prolactin, and corticosterone responses. Endocrinology 1994; 134: 1127–1131
   PubMedGoogle Scholar
• Baliga RR, Ranganna P, Pitt B, Koelling TM. Spironolactone treatment and clinical outcomes in patients with systolic dysfunction and mild heart failure symptoms: A retrospective analysis. J Card Fail 2006; 12: 250–256
   PubMedGoogle Scholar
• Banki CM, Karmacsi L, Bissette G, Nemeroff CB. CSF corticotropin-releasing hormone and somatostatin in major depression: Response to antidepressant treatment and relapse. Eur Neuropsychopharmacol 1992; 2: 107–113
   PubMedGoogle Scholar
• Banks WA, Kastin AJ, Broadwell RD. Passage of cytokines across the blood–brain barrier. Neuroimmunomodulation 1995; 2: 241–248
   PubMed Web of Science ®Google Scholar
• Barden N, Reul JM, Holsboer F. Do antidepressants stabilize mood through actions on the hypothalamic–pituitary–adrenocortical system?. Trends Neurosci 1995; 18: 6–11
   PubMed Web of Science ®Google Scholar
• Barefoot JC, Schroll M. Symptoms of depression, acute myocardial infarction, and total mortality in a community sample. Circulation 1996; 93: 1976–1980
   PubMed Web of Science ®Google Scholar
• Barefoot JC, Helms MJ, Mark DB, Blumenthal JA, Califf RM, Haney TL, O'Connor CM, Siegler IC, Williams RB. Depression and long-term mortality risk in patients with coronary artery disease. Am J Cardiol 1996; 78: 613–617
   PubMed Web of Science ®Google Scholar
• Barton DA, Dawood T, Lambert EA, Esler MD, Haikerwal D, Brenchley C, Socratous F, Kaye DM, Schlaich MP, Hickie I, Lambert GW. Sympathetic activity in major depressive disorder: Identifying those at increased cardiac risk?. J Hypertens 2007; 25: 2117–2124
   PubMed Web of Science ®Google Scholar
• Bataillard A, del Rey A, Klusman I, Arditi GM, Besedovsky HO. Interleukin-1 stimulates aldosterone secretion: Involvement of renin, ACTH, and prostaglandins. Am J Physiol Regul Integr Comp Physiol 1992; 263: R840–R844
   Google Scholar
• Bedi M, Varshney VP, Babbar R. Role of cardiovascular reactivity to mental stress in predicting future hypertension. Clin Exp Hypertens 2000; 22: 1–22
   PubMed Web of Science ®Google Scholar
• Beere PA, Glagov S, Zarins CK. Retarding effect of lowered heart rate on coronary atherosclerosis. Science 1984; 226: 180–182
   PubMed Web of Science ®Google Scholar
• Beniamini Y, Rubenstein JJ, Zaichkowsky LD, Crim MC. Effects of high-intensity strength training on quality-of-life parameters in cardiac rehabilitation patients. Am J Cardiol 1997; 80: 841–846
   PubMed Web of Science ®Google Scholar
• Berendsen HHG. Interactions between 5-hydroxytryptamine receptor subtypes: Is a disturbed receptor balance contributing to the symptomatology of depression in humans?. Pharmacol Ther 1995; 66: 17–37
   PubMed Web of Science ®Google Scholar
• Berman RM, Belanoff JK, Charney DS, Schatzberg AF. Principles of the pharmacotherapy of depression. Neurobiology of mental illness, DS Charney, EJ Nestler, BS Bunney. Oxford University Press, New York 1999; 419–432
   Google Scholar
• Bidzinska EJ. Stress factors in affective diseases. Br J Psychiatry 1984; 144: 161–166
   PubMed Web of Science ®Google Scholar
• Billman GE, Schwartz PJ, Stone HL. Baroreceptor reflex control of heart rate: A predictor of sudden cardiac death. Circulation 1982; 66: 874–880
   PubMedGoogle Scholar
• Bissette G, Klimek V, Pan J, Stockmeier C, Ordway G. Elevated concentrations of CRF in the locus coeruleus of depressed subjects. Neuropsychopharmacology 2003; 28: 1328–1335
   PubMed Web of Science ®Google Scholar
• Blier P. Pharmacology of rapid-onset antidepressant treatment strategies. J Clin Psychiatry 2001; 62(Suppl. 15)12–17
   PubMed Web of Science ®Google Scholar
• Bollini P, Pampallona S, Kupelnick B, Tibaldi G, Munizza C. Improving compliance in depression: A systematic review of narrative reviews. J Clin Pharm Ther 2006; 31: 253–260
   PubMed Web of Science ®Google Scholar
• Booth-Kewley S, Friedman HS. Psychological predictors of heart disease: A quantitative review. Psychol Bull 1987; 101: 343–362
   PubMed Web of Science ®Google Scholar
• Braith RW. Exercise training in patients with CHF and heart transplant recipients. Med Sci Sports Exerc 1998; 30(Suppl. 10)S367–S378
   PubMedGoogle Scholar
• Bruce EC, Musselman DL. Depression, alterations in platelet function, and ischemic heart disease. Psychosom Med 2005; 67(Suppl. 1)S34–S36
   PubMedGoogle Scholar
• Bruce ML, Seeman TE, Merrill SS, Blazer DG. The impact of depressive symptomatology on physical disability: MacArthur studies of successful aging. Am J Public Health 1994; 84: 1796–1799
   PubMed Web of Science ®Google Scholar
• Carney RM, Freedland KE. Depression, mortality, and medical morbidity in patients with coronary heart disease. Biol Psychiatry 2003; 54: 241–247
   PubMed Web of Science ®Google Scholar
• Carney RM, Rich MW, Freedland KE, Saini J, teVelde A, Simeone C, Clark K. Major depressive disorder predicts cardiac events in patients with coronary artery disease. Psychosom Med 1988a; 50: 627–633
   PubMed Web of Science ®Google Scholar
• Carney RM, Rich MW, teVelde A, Saini J, Clark K, Freedland KE. The relationship between heart rate, heart rate variability and depression in patients with coronary artery disease. J Psychosom Res 1988b; 32: 159–164
   PubMed Web of Science ®Google Scholar
• Carney RM, Freedland KE, Rich MW, Smith LJ, Jaffe AS. Ventricular tachycardia and psychiatric depression in patients with coronary artery disease. Am J Med 1993; 95: 23–28
   PubMed Web of Science ®Google Scholar
• Carney RM, Freedland KE, Rich MW, Jaffe AS. Depression as a risk factor for cardiac events in established coronary heart disease: A review of possible mechanisms. Ann Behav Med 1995a; 17: 142–149
   PubMed Web of Science ®Google Scholar
• Carney RM, Saunders RD, Freedland KE, Stein P, Rich MW, Jaffe AS. Association of depression with reduced heart rate variability in coronary artery disease. Am J Cardiol 1995b; 76: 562–564
   PubMed Web of Science ®Google Scholar
• Carney RM, Freedland KE, Veith RC, Jaffe AS. Can treating depression reduce mortality after an acute myocardial infarction?. Psychosom Med 1999; 61: 666–675
   PubMed Web of Science ®Google Scholar
• Carney RM, Freedland KE, Stein PK, Skala JA, Hoffman P, Jaffe AS. Change in heart rate and heart rate variability during treatment for depression in patients with coronary heart disease. Psychosom Med 2000; 62: 639–647
   PubMed Web of Science ®Google Scholar
• Carpeggiani C, Skinner JE. Coronary flow and mental stress. Experimental findings. Circulation 1991; 83: II-90–II-93
   Google Scholar
• Carroll BJ. Limbic system-adrenal cortex regulation in depression and schizophrenia. Psychosom Med 1976; 38: 106–121
   PubMed Web of Science ®Google Scholar
• Carroll BJ, Curtis GC, Mendels J. Neuroendocrine regulation in depression II. discrimination of depressed from nondepressed patients. Arch Gen Psychiatry 1976a; 33: 1051–1058
   PubMed Web of Science ®Google Scholar
• Carroll BJ, Curtis GC, Mendels J. Neuroendocrine regulation in depression: I. limbic sytem-adrenocortical dysfunction. Arch Gen Psychiatry 1976b; 33: 1039–1044
   PubMed Web of Science ®Google Scholar
• Cassidy EM, O'Keane V. Depression and interferon-alpha therapy. Br J Psychiatry 2000; 176: 494
   PubMedGoogle Scholar
• Catterall WA, Ray R. Interactions of neurotoxins with the action potential NA+ionophore. J Supramol Struct 1976; 5: 397–407
   PubMedGoogle Scholar
• Centers for Disease Control and Prevention and National Center for Infectious Diseases. Chronic fatigue syndrome. U.S. Department of Health and Human Services, Washington, D.C. 2001
   Google Scholar
• Cheeta S, Broekkamp C, Willner P. Stereospecific reversal of stress-induced anhedonia by mianserin and its (+)-enantiomer. Psychopharmacology 1994; 116: 523–528
   PubMed Web of Science ®Google Scholar
• Clement HW, Buschmann J, Rex S, Grote C, Opper C, Gemsa D, Wesemann W. Effects of interferon-γ, interleukin-1β and tumor necrosis factor-α on the serotonin metabolism in the nucleus raphe dorsalis of the rat. J Neural Transm 1997; 104: 981–991
   PubMed Web of Science ®Google Scholar
• Collins HL, DiCarlo SE. Daily exercise attenuates the sympathetic component of the arterial baroreflex control of heart rate. Am J Physiol Heart Circ Physiol 1997; 273: H2613–H2619
   PubMed Web of Science ®Google Scholar
• Connor TJ, Leonard BE. Depression, stress, and immunological activation: The role of cytokines in depressive disorders. Life Sci 1998; 62: 583–606
   PubMed Web of Science ®Google Scholar
• Connor TJ, Song C, Leonard BE, Merali Z, Anisman H. An assessment of the effects of central interleukin-1β, ‐2, ‐6, and tumor necrosis factor-α administration on some behavioural, neurochemical, endocrine, and immune parameters in the rat. Neuroscience 1998; 84: 923–933
   PubMed Web of Science ®Google Scholar
• Corbalan R, Verrier R, Lown B. Psychological stress and ventricular arrhythmias during myocardial infarction in the conscious dog. Am J Cardiol 1974; 34: 692–696
   PubMedGoogle Scholar
• Cryan JF, Valentino RJ, Lucki I. Assessing substrates underlying the behavioral effects of antidepressants using the modified rat forced swimming test. Neurosci Biobehav Rev 2005; 29: 547–569
   PubMed Web of Science ®Google Scholar
• Cunningham ET, Jr, De Souza EB. Interleukin 1 receptors in the brain and endocrine tissues. Immunol Today 1993; 14: 171–176
   PubMedGoogle Scholar
• Dantzer R. How do cytokines say hello to the brain? Neural vs. humoral mediation. Eur Cytokine Netw 1994; 5: 271–273
   PubMedGoogle Scholar
• Dantzer R. Cytokine, sickness behavior, and depression. Neurol Clin 2006; 24: 441–460
   PubMed Web of Science ®Google Scholar
• Dantzer R, Bluthé RM, Gheusi G, Cremona S, Layé S, Parnet P, Kelley KW. Molecular basis of sickness behavior. Ann NY Acad Sci 1998; 856: 132–138
   PubMed Web of Science ®Google Scholar
• Das UN. Free radicals, cytokines and nitric oxide in cardiac failure and myocardial infarction. Mol Cell Biochem 2000; 215: 145–152
   PubMed Web of Science ®Google Scholar
• Dawood T, Lambert EA, Barton DA, Laude D, Elghozi J-L, Esler MD, Haikerwal D, Kaye DM, Hotchkin EJ, Lambert GW. Specific serotonin reuptake inhibition in major depressive disorder adversely affects novel markers of cardiac risk. Hypertens Res 2007; 30: 285–293
   PubMed Web of Science ®Google Scholar
• De La Garza R, II. Endotoxin- or pro-inflammatory cytokine-induced sickness behavior as an animal model of depression: Focus on anhedonia. Neurosci Biobehav Rev 2005; 29: 761–770
   PubMed Web of Science ®Google Scholar
• Doner K. Depression: Is it all in your heart?. My Generation 2002; 48, July-August
   Google Scholar
• Duman RS. The neurochemistry of mood disorders: Preclinical studies. Neurobiology of mental illness, DS Charney, EJ Nestler, BS Bunney. Oxford University Press, New York 1999; 333–347
   Google Scholar
• Dunn AJ, Wang J, Ando T. Effects of cytokines on cerebral neurotransmission: Comparison with the effects of stress. Cytokines, stress, and depression, R Dantzer, EE Wollmann, R Yirmiya. Kluwer Academic/Plenum, New York 1999; 117–127
   Google Scholar
• Dunn AJ, Swiergiel AH, de Beaurepaire R. Cytokines as mediators of depression: What can we learn from animal studies?. Neurosci Biobehav Rev 2005; 29: 891–909
   PubMed Web of Science ®Google Scholar
• Dyer AR, Persky V, Stamler J, Paul O, Shekelle RB, Berkson DM, Lepper M, Schoenberger JA, Lindberg HA. Heart rate as a prognostic factor for coronary heart disease and mortality: Findings in three Chicago epidemiologic studies. Am J Epidemiol 1980; 112: 736–749
   PubMed Web of Science ®Google Scholar
• Emanuele E, Geroldi D, Minoretti P, Coen E, Politi P. Increased plasma aldosterone in patients with clinical depression. Arch Med Res 2005; 36: 544–548
   PubMed Web of Science ®Google Scholar
• Esler M, Kaye D. Sympathetic nervous system activation in essential hypertension, cardiac failure and psychosomatic heart disease. J Cardiovasc Pharmacol 2000; 35(Suppl. 4)S1–S7
   PubMedGoogle Scholar
• Esler M, Turbott J, Schwarz R, Leonard B, Bobik A, Skews H, Jackman G. The peripheral kinetics of norepinephrine in depressive illness. Arch Gen Psychiatry 1982; 39: 295–300
   PubMedGoogle Scholar
• Esler M, Lambert E, Alvarenga M, Socratous F, Richards J, Barton D, Pier C, Brenchley C, Dawood T, Hastings J, Guo L, Haikerwal D, Kaye D, Jennings G, Kalff V, Kelly M, Wiesner G, Lambert G. Increased brain serotonin turnover in panic disorder patients in the absence of a panic attack: Reduction by a selective serotonin reuptake inhibitor. Stress 2007; 10: 295–304
   PubMed Web of Science ®Google Scholar
• Evans DL, Charney DS, Lewis L, Golden RN, Gorman JM, Krishnan KRR, Nemeroff CB, Bremner JD, Carney RM, Coyne JC, Delong MR, Frasure-Smith N, Glassman AH, Gold PW, Grant I, Gwyther L, Ironson G, Johnson RL, Kanner AM, Katon WJ, Kaufmann PG, Keefe FJ, Ketter T, Laughren TP, Leserman J, Lyketsos CG, McDonald WM, McEwen BS, Miller AH, Musselman D, O'Connor C, Petitto JM, Pollock BG, Robinson RG, Roose SP, Rowland J, Sheline Y, Sheps DS, Simon G, Spiegel D, Stunkard A, Sunderland T, Tibbits P, Jr, Valvo W, Jr. Mood disorders in the medically ill: Scientific review and recommendations. Biol Psychiatry 2005; 58: 175–189
   PubMed Web of Science ®Google Scholar
• Everson SA, Goldberg DE, Kaplan GA, Cohen RD, Pukkala E, Tuomilehto J, Salonen JT. Hopelessness and risk of mortality and incidence of myocardial infarction and cancer. Psychosom Med 1996; 58: 113–121
   PubMed Web of Science ®Google Scholar
• Everson-Rose SA, House JS, Mero RP. Depressive symptoms and mortality risk in a national sample: Confounding effects of health status. Psychosom Med 2004; 66: 823–830
   PubMed Web of Science ®Google Scholar
• Felder RB, Francis J, Weiss RM, Zhang ZH, Wei SG, Johnson AK. Neurohumoral regulation in ischemia-induced heart failure. Role of the forebrain. Ann NY Acad Sci 2001; 940: 444–453
   PubMedGoogle Scholar
• Felder RB, Francis J, Zhang ZH, Wei SG, Weiss RM, Johnson AK. Heart failure and the brain: New perspectives. Am J Physiol Regul Integr Comp Physiol 2003; 284: R259–R276
   PubMedGoogle Scholar
• Feldman S, Weidenfeld J. Depletion of hypothalamic norepinephrine and serotonin enhances the dexamethasone negative feedback effect on adrenocortical secretion. Psychoneuroendocrinology 1991; 16: 397–405
   PubMedGoogle Scholar
• Fenton WS, Stover ES. Mood disorders: Cardiovascular and diabetes comorbidity. Curr Opin Psychiatry 2006; 19: 421–427
   PubMed Web of Science ®Google Scholar
• Ferrari R. The role of TNF in cardiovascular disease. Pharmacol Res 1999; 40: 97–105
   PubMed Web of Science ®Google Scholar
• Ferrari R, Censi S, Mastrorilli F, Boraso A. Prognostic benefits of heart rate reduction in cardiovascular disease. Eur Heart J 2003; 5(Suppl. G)G10–G14
   Google Scholar
• Foley KF, DeSanty KP, Kast RE. Bupropion: Pharmacology and therapeutic applications. Expert Rev Neurother 2006; 6: 1249–1265
   PubMed Web of Science ®Google Scholar
• Forbes LM, Chaney RH. Cardiovascular changes during acute depression. Psychosomatics 1980; 21: 472–477
   PubMedGoogle Scholar
• Francis J, Weiss RM, Wei SG, Johnson AK, Beltz TG, Zimmerman K, Felder RB. Central mineralocorticoid receptor blockade improves volume regulation and reduces sympathetic drive in heart failure. Am J Physiol Heart Circ Physiol 2001a; 281: H2241–H2251
   PubMed Web of Science ®Google Scholar
• Francis J, Weiss RM, Wei SG, Johnson AK, Felder RB. Progression of heart failure after myocardial infarction in the rat. Am J Physiol Regul Integr Comp Physiol 2001b; 281: R1734–R1745
   PubMedGoogle Scholar
• Francis J, Beltz TG, Johnson AK, Felder RB. Mineralocorticoids act centrally to regulate blood-borne tumor necrosis factor-alpha in nornal rats. Am J Physiol Regul Integr Comp Physiol 2003a; 285: R1402–R1409
   PubMedGoogle Scholar
• Francis J, Weiss RM, Johnson AK, Felder RB. Central mineralocorticoid receptor blockade decreases plasma TNF-α after coronary artery ligation in rats. Am J Physiol Regul Integr Comp Physiol 2003b; 284: R328–R335
   PubMedGoogle Scholar
• Francis J, Zhang ZH, Weiss RM, Felder RB. Neural regulation of the proinflammatory cytokine response to acute myocardial infarction. Am J Physiol Heart Circ Physiol 2004; 287: H791–H797
   PubMedGoogle Scholar
• Frasure-Smith N, Lespérance F. Depression and other psychological risks following myocardial infarction. Arch Gen Psychiatry 2003; 60: 627–636
   PubMed Web of Science ®Google Scholar
• Frasure-Smith N, Lespérance F, Talajic M. Depression following myocardial infarction: Impact on 6-month survival. JAMA 1993; 270: 1819–1825
   PubMed Web of Science ®Google Scholar
• Frasure-Smith N, Lespérance F, Talajic M. Depression and 18-month prognosis after myocardial infarction. Circulation 1995; 91: 999–1005
   PubMed Web of Science ®Google Scholar
• Frazer A, Morilak DA. What should animal models of depression model?. Neurosci Biobehav Rev 2005; 29: 515–523
   PubMed Web of Science ®Google Scholar
• Freedland KE, Rich MW, Skala JA, Carney RM, Dávila-Román VG, Jaffe AS. Prevalence of depression in hospitalized patients with congestive heart failure. Psychosom Med 2003; 65: 119–128
   PubMed Web of Science ®Google Scholar
• Freedland KE, Miller GE, Sheps DS. The great debate, revisited. Psychosom Med 2006; 68: 179–184
   PubMed Web of Science ®Google Scholar
• Froger N, Palazzo E, Boni C, Hanoun N, Saurini F, Joubert C, Dutriez-Casteloot I, Enache M, Barden N, Cohen-Salmon C, Hamon M, Lanfumey L. Neurochemical and behavioral alterations in glucocorticoid receptor-impaired transgenic mice after chronic mild stress. J Neurosci 2004; 24: 2787–2796
   PubMedGoogle Scholar
• Fuller RW. Serotonin receptors involved in regulation of pituitary-adrenocortical function in rats. Behav Brain Res 1996; 73: 215–219
   PubMedGoogle Scholar
• Fumeron F, Betoulle D, Nicaud V, Evans A, Kee F, Ruidavets JB, Arveiler D, Luc G, Cambien F. Serotonin transporter gene polymorphism and myocardial infarction: Etude Cas-Temoins de l'Infarctus du Myocarde (ECTIM). Circulation 2002; 105: 2943–2945
   PubMedGoogle Scholar
• Garlow SJ, Nemeroff CB. The neurochemistry of mood disorders: Clinical studies. Neurobiology of mental illness2nd ed., DS Charney, EJ Nestler. Oxford University Press, New York 2004; 440–460
   Google Scholar
• Gheorghiade M, Abraham WT, Albert NM, Gattis Stough W, Greenberg BH, O'Connor CM, She L, Yancy CW, Young J, Fonarow GC, OPTIMIZE-HF Investigators and Coordinators. Relationship between admission serum sodium concentration and clinical outcomes in patients hospitalized for heart failure: An analysis from the OPTIMIZE-HF registry. Eur Heart J 2007a; 28: 980–988
   PubMed Web of Science ®Google Scholar
• Gheorghiade M, Rossi JS, Cotts W, Shin DD, Hellkamp AS, Piña IL, Fonarow GC, DeMarco T, Pauly DF, Rogers J, DiSalvo TG, Butler J, Hare JM, Francis GS, Stough WG, O'Connor CM. Characterization and prognostic value of persistent hyponatremia in patients with severe heart failure in the ESCAPE Trial. Arch Int Med 2007b; 167: 1998–2005
   PubMed Web of Science ®Google Scholar
• Glassman AH. Depression and cardiovascular comorbidity. Dialogues Clin Neurosci 2007; 9: 9–17
   PubMedGoogle Scholar
• Glassman AH, Shapiro PA. Depression and the course of coronary artery disease. Am J Psychiatry 1998; 155: 4–11
   PubMed Web of Science ®Google Scholar
• Glowa JR, Gold PW. Corticotropin releasing hormone produces profound anorexigenic effects in the rhesus monkey. Neuropeptides 1991; 18: 55–61
   PubMed Web of Science ®Google Scholar
• Gold PW, Wong M-L, Goldstein DS, Gold HK, Ronsaville DS, Esler M, Alesci S, Masood A, Licinio J, Geracioti TD, Perini G, DeBellis MD, Holmes C, Vgontzas AN, Charney DS, Chrousos GP, McCann SM, Kling MA. Cardiac implications of increased arterial entry and reversible 24-h central and peripheral norepinephrine levels in melancholia. Proc Natl Acad Sci USA 2005; 102: 8303–8308
   PubMed Web of Science ®Google Scholar
• Goldstein DS. Plasma catecholamines and essential hypertension: An analytical review. Hypertension 1983; 5: 86–99
   PubMed Web of Science ®Google Scholar
• Gomez-Sanchez EP. Brain mineralocorticoid receptors: Orchestrators of hypertension and end-organ disease. Curr Opin Nephrol Hypertens 2004; 13: 191–196
   PubMedGoogle Scholar
• Gordon D, Guyton JR, Karnovsky N. Intimal alterations in rat aorta induced by stressful stimuli. Lab Invest 1981; 45: 14–27
   PubMedGoogle Scholar
• Greene WA, Goldstein S, Moss AJ. Psychosocial aspects of sudden death. A preliminary report. Arch Int Med 1972; 129: 725–731
   PubMed Web of Science ®Google Scholar
• Grippo AJ, Moffitt JA, Johnson AK. Cardiovascular alterations and autonomic imbalance in an experimental model of depression. Am J Physiol Regul Integr Comp Physiol 2002; 282: R1333–R1341
   PubMed Web of Science ®Google Scholar
• Grippo AJ, Beltz TG, Johnson AK. Behavioral and cardiovascular changes in the chronic mild stress model of depression. Physiol Behav 2003a; 78: 703–710
   PubMed Web of Science ®Google Scholar
• Grippo AJ, Francis J, Weiss RM, Felder RB, Johnson AK. Cytokine mediation of experimental heart failure-induced anhedonia. Am J Physiol Regul Integr Comp Physiol 2003b; 284: R666–R673
   PubMedGoogle Scholar
• Grippo AJ, Santos CM, Johnson RF, Beltz TG, Martins JB, Felder RB, Johnson AK. Increased susceptibility to ventricular arrhythmias in a rodent model of experimental depression. Am J Physiol Heart Circ Physiol 2004; 286: H619–H626
   PubMed Web of Science ®Google Scholar
• Grippo AJ, Francis J, Beltz TG, Felder RB, Johnson AK. Neuroendocrine and cytokine profile of chronic mild stress-induced anhedonia. Physiol Behav 2005a; 84: 697–706
   PubMed Web of Science ®Google Scholar
• Grippo AJ, Sullivan NR, Damjanoska KJ, Crane JW, Carrasco GA, Shi J, Chen Z, Garcia F, Muma NA, Van de Kar LD. Chronic mild stress induces behavioral and physiological changes, and may alter serotonin 1A receptor function, in male and cycling female rats. Psychopharmacology 2005b; 179: 769–780
   PubMed Web of Science ®Google Scholar
• Grippo AJ, Beltz TG, Weiss RM, Johnson AK. The effects of chronic fluoxetine treatment on chronic mild stress-induced cardiovascular changes and anhedonia. Biol Psychiatry 2006a; 59: 309–316
   PubMed Web of Science ®Google Scholar
• Grippo AJ, Moffitt JA, Beltz TG, Johnson AK. Reduced hedonic behavior and altered cardiovascular function induced by mild sodium depletion in rats. Behav Neurosci 2006b; 120: 1133–1143
   PubMedGoogle Scholar
• Grippo AJ, Wu KD, Hassan I, Carter CS. Social isolation in prairie voles induces behaviors relevant to negative affect: Toward the development of a rodent model focused on co-occurring depression and anxiety. Depress Anxiety 2008, in press
   PubMedGoogle Scholar
• Gutiérrez B, Arias B, Papiol S, Rosa A, Fañanás L. Association study between novel promoter variants and the 5-HT2C receptor gene and human patients with bipolar affective disorder. Neurosci Lett 2001; 309: 135–137
   PubMed Web of Science ®Google Scholar
• Hausberg M, Hillebrand U, Kisters K. Addressing sympathetic overactivity in major depressive disorder. J Hypertens 2007; 25: 2004–2005
   PubMedGoogle Scholar
• Hawkley LC, Bosch JA, Engeland CG, Marucha PT, Cacioppo JT. Loneliness, dysphoria, stress, and immunity: A role for cytokines. Cytokines: Stress and immunity2nd ed., NP Plotnikoff, RE Faith, AJ Murgo, RA Good, 2007; 67–85
   Google Scholar
• Herman JP, Guillonneau D, Dantzer R, Scatton B, Semerdjian-Rouquier L, LeMoal M. Differential effects of inescapable footshocks and of stimuli previously paired with inescapable footshocks on dopamine turnover in cortical and limbic areas of the rat. Life Sci 1982; 30: 2207–2214
   PubMedGoogle Scholar
• Hickie I, Lloyd A, Wakefield D, Parker G. The psychiatric status of patients with the chronic fatigue syndrome. Br J Psychiatry 1990; 156: 534–540
   PubMed Web of Science ®Google Scholar
• Honerjager P, Meissner A. The positive inotropic effect of aconitine. Naunyn-Schmiedebergs Arch Pharmacol 1983; 322: 49–58
   PubMed Web of Science ®Google Scholar
• Hopkins SJ, Rothwell NJ. Cytokines and the nervous system I: Expression and recognition. Trends Neurosci 1995; 18: 83–88
   PubMed Web of Science ®Google Scholar
• Huangfu D, Hwang LJ, Riley TA, Guyenet PG. Role of serotonin and catecholamines in sympathetic responses evoked by stimulation of rostral medulla. Am J Physiol Regul Integr Comp Physiol 1994; 266: R338–R352
   Google Scholar
• Irwin J, Ahluwalia P, Anisman H. Sensitization of norepinephrine activity following acute and chronic footshock. Brain Res 1986; 379: 98–103
   PubMedGoogle Scholar
• Jarskog LF, Xiao H, Wilkie MB, Lauder JM, Gilmore JH. Cytokine regulation of embryonic rat dopamine and serotonin neuronal survival in vitro. Int J Dev Neurosci 1997; 15: 711–716
   PubMed Web of Science ®Google Scholar
• Johnson AK, Anderson EA. Stress and arousal. Principles of psychophysiology: Physical, social, and inferential elements, JT Cacioppo, LG Tassinary. Cambridge University Press, Cambridge 1990; 216–252
   Google Scholar
• Johnson AK, Thunhorst RL. The neuroendocrinology of thirst and salt appetite: Visceral sensory signals and mechanisms of central integration. Front Neuroendocrinol 1997; 18: 292–353
   PubMed Web of Science ®Google Scholar
• Johnson AK, Grippo AJ. Sadness and broken hearts: Neurohumoral mechanisms and co-morbidity of ischemic heart disease and psychological depression. J Physiol Pharmacol 2006; 57: 5–29, (Suppl. 11):
   PubMed Web of Science ®Google Scholar
• Johnson AK, Thunhorst RL. The neuroendocrinology, neurochemistry and molecular biology of thirst and salt appetite. Handbook of neurochemistry and molecular neurobiology: Behavioral neurochemistry, neuroendocrinology and molecular neurobiology3rd ed, A Lajtha, JD Blaustein, 2007; 641–687
   Google Scholar
• Joseph MH, Kennett GA. Stress-induced release of 5-HT in the hippocampus and its dependence on increased tryptophan availability: An in vivo electrochemical study. Brain Res 1983; 270: 251–257
   PubMedGoogle Scholar
• Kabiersch A, del Rey A, Honegger CG, Besedovsky HO. Interleukin-1 induces changes in norepinephrine metabolism in the rat brain. Brain Behav Immun 1988; 2: 267–274
   PubMedGoogle Scholar
• Kannel WB, Kannel C, Paffenbarger RS, Jr, Cupples LA. Heart rate and cardiovascular mortality: The Framingham study. Am Heart J 1987; 113: 1489–1494
   PubMed Web of Science ®Google Scholar
• Kapadia S, Dibbs Z, Kurrelmeyer K, Karla D, Seta Y, Wang F, Bozkurt B, Oral H, Sivasubramanian N, Mann DL. The role of cytokines in the failing human heart. Cardiol Clin 1998; 16: 645–656
   PubMedGoogle Scholar
• Khaykin Y, Dorian P, Baker B, Shapiro C, Sandor P, Mironov D, Irvine J, Newman D. Autonomic correlates of antidepressant treatment using heart-rate variability analysis. Can J Psychiatry 1998; 43: 183–186
   PubMedGoogle Scholar
• Kjekshus JK, Blix AS, Grottum P, Aasen AO. Beneficial effects of vagal stimulation on the ischaemic myocardium during beta-receptor blockade. Scand J Clin Lab Invest 1981; 41: 383–389
   PubMed Web of Science ®Google Scholar
• Kleiger RE, Miller JP, Bigger JT, Moss AJ. Decreased heart rate variability and its association with increased mortality after acute myocardial infarction. Am J Cardiol 1987; 59: 256–262
   PubMed Web of Science ®Google Scholar
• Klimas NG, Salvato FR, Morgan R, Fletcher MA. Immunologic abnormalities in chronic fatigue syndrome. J Clin Microbiol 1990; 28: 1403–1410
   PubMed Web of Science ®Google Scholar
• Klimas NG, Morgan R, Van Riel F, Fletcher MA. Observations regarding use of an antidepressant, fluoxetine, in chronic fatigue syndrome. Chronic fatigue and related immune deficiency syndromes, PJ Goodnick, NG Klimas. American Psychiatric Press, Inc, Washington, DC 1993; 95–108
   Google Scholar
• Knardahl S, Sanders BJ, Johnson AK. Effects of adrenal demedullation on stress-induced hypertension and cardiovascular responses to acute stress. Acta Physiol Scand 1988; 133: 477–483
   PubMedGoogle Scholar
• Kop WJ. Chronic and acute psychological risk factors for clinical manifestations of coronary artery disease. Psychosom Med 1999; 61: 476–487
   PubMed Web of Science ®Google Scholar
• Kotulak R. The healing mind. Chicago Tribute Magazine 2006; 15–16: 29–31
   Google Scholar
• Krahn DD, Gosnell BA, Levine AS, Morley JE. Behavioral effects of corticotropin-releasing factor: Localization and characterization of central effects. Brain Res 1988; 443: 63–69
   PubMedGoogle Scholar
• Kristal-Boneh E, Raifel M, Froom P, Ribak J. Heart rate variability in health and disease. Scand J Work Environ Health 1995; 21: 85–95
   PubMed Web of Science ®Google Scholar
• Krittayaphong R, Cascio WE, Light KC, Sheffield D, Golden RN, Finkel JB, Glekas G, Koch GG, Sheps DS. Heart rate variability in patients with coronary artery disease: Differences in patients with higher and lower depression scores. Psychosom Med 1997; 59: 231–235
   PubMed Web of Science ®Google Scholar
• Kronfol Z. Immune dysregulation in major depression: A critical review of existing evidence. Int J Neuropsychopharmacol 2002; 5: 333–343
   PubMedGoogle Scholar
• Krueger JM, Walter J, Dinarello CA, Wolff SM, Chedid L. Sleep-promoting effects of endogenous pyrogen (interleukin-1). Am J Physiol Regul Integr Comp Physiol 1984; 246: R994–R999
   PubMed Web of Science ®Google Scholar
• Kusumi I, Koyama T, Yamashita I. Serotonin-stimulated Ca2+ response is increased in the blood platelets of depressed patients. Biol Psychiatry 1991; 30: 310–312
   PubMedGoogle Scholar
• La Rovere MT, Bigger JT, Jr, Marcus FI, Mortara A, Schwartz PJ. Baroreflex sensitivity and heart-rate variability in prediction of total cardiac mortality after myocardial infarction. Lancet 1998; 351: 478–484
   PubMed Web of Science ®Google Scholar
• Lambert G, Johansson M, Ågren H, Friberg P. Reduced brain norepinephrine and dopamine release in treatment-refractory depressive illness: Evidence in support of the catecholamine hypothesis of mood disorders. Arch Gen Psychiatry 2000; 57: 787–793
   PubMed Web of Science ®Google Scholar
• Lebovits BZ, Shekelle RB, Ostfeld AM, Paul O. Prospective and retrospective psychological studies of coronary heart disease. Psychosom Med 1967; 29: 265–272
   PubMedGoogle Scholar
• Lechin F, van der Dijs B, Orozco B, Lechin ME, Báez S, Lechin AE, Rada I, Acosta E, Arocha L, Jiménez V, León G, García Z. Plasma neurotransmitters, blood pressure, and heart rate during supine-resting, orthostasis, and moderate exercise conditions in major depressed patients. Biol Psychiatry 1995; 38: 166–173
   PubMed Web of Science ®Google Scholar
• LeJemtel TH, Serrano C. Vasopressin dysregulation: Hyponatremia, fluid retention and congestive heart failure. Int J Cardiol 2007; 120: 1–9
   PubMed Web of Science ®Google Scholar
• Lerer B, Macciardi F, Segman RH, Adolfsson R, Blackwood D, Blairy S, Del Favero J, Dikeos DG, Kaneva R, Lilli R, Massat I, Milanova V, Muir W, Noethen M, Oruc L, Petrova T, Papadimitriou GN, Rietschel M, Serretti A, Souery D, Van Gestel S, Van Broeckhoven C, Mendlewicz J. Variability of 5-HT2C receptor cys23ser polymorphism among European populations and vulnerability to affective disorders. Mol Psychiatry 2001; 6: 579–585
   PubMed Web of Science ®Google Scholar
• Levine B, Kalman J, Mayer L, Fillit HM, Packer M. Elevated circulating levels of tumor necrosis factor in severe chronic heart failure. N Engl J Med 1990; 323: 236–241
   PubMed Web of Science ®Google Scholar
• Lown B, Verrier RL. Neural activity and ventricular fibrillation. N Engl J Med 1976; 294: 1165–1170
   PubMed Web of Science ®Google Scholar
• Lucki I. The spectrum of behaviors influenced by serotonin. Biol Psychiatry 1998; 44: 151–162
   PubMed Web of Science ®Google Scholar
• Maes M. Evidence for an immune response in major depression: A review and hypothesis. Prog Neuropsychopharmacol Biol Psychiatry 1995; 19: 11–38
   PubMed Web of Science ®Google Scholar
• Maes M, Meltzer HY. The serotonin hypothesis of major depression. Psychopharmacology: The fourth generation of progress, FE Bloom, DJ Kupfer. Raven Press, New York 1995; 933–944
   Google Scholar
• Maes M, Lin A, Bonaccorso S, van Hunsel F, Van Gastel A, Delmeire L, Biondi M, Bosmans E, Kenis G, Scharpe S. Increased 24-h uninary cortisol excretion in patients with post-traumatic stress disorder and patients with major depression, but not in patients with fibromyalgia. Acta Psychiatr Scand 1998; 98: 328–335
   PubMed Web of Science ®Google Scholar
• Maier SF, Watkins LR. Cytokines for psychologists: Implications of bidirectional immune-to-brain communication for understanding behavior, mood, and cognition. Psychol Rev 1998; 105: 83–107
   PubMed Web of Science ®Google Scholar
• Maier SF, Watkins LR. Stressor controllability and learned helplessness: The roles of the dorsal raphe nucleus, serotonin, and corticotropin-releasing factor. Neurosci Biobehav Rev 2005; 29: 829–841
   PubMed Web of Science ®Google Scholar
• Mathers CD, Loncar D. Updated projections of global mortality and burden of disease, 2002–2030: Data sources, methods and results. World Health Organization, Geneva 2005
   Google Scholar
• Matta RJ, Lawler JE, Lown B. Ventricular electrical instability in the conscious dog: Effects of psychologic stress and beta adrenergic blockade. Am J Cardiol 1976; 38: 594–598
   PubMedGoogle Scholar
• McCartney N. Role of resistance training in heart disease. Med Sci Sports Exerc 1998; 30: S396–S402
   PubMedGoogle Scholar
• Meltzer HY. Role of serotonin in depression. Ann NY Acad Sci 1990; 600: 486–499
   PubMed Web of Science ®Google Scholar
• Mendes de Leon CF, Krumholz HM, Seeman TS, Vaccarino V, Williams CS, Kasl SV, Berkman LF. Depression and risk of coronary heart disease in elderly men and women. Arch Int Med 1998; 158: 2341–2348
   PubMedGoogle Scholar
• Mikuni M, Kusumi I, Kagaya A, Kuroda Y, Mori H, Takahashi K. Increased 5-HT-2 receptor function as measured by serotonin-stimulated phosphoinositide hydrolysis in platelets of depressed patients. Prog Neuropsychopharmacol Biol Psychiatry 1991; 15: 49–61
   PubMedGoogle Scholar
• Miller MC. The dangers of chronic distress. Newsweek 2005; 58–59, October 3
   Google Scholar
• Moffitt JA, Johnson AK. Short-term fluoxetine treatment enhances baroreflex control of sympathetic nervous system activity after hindlimb unloading. Am J Physiol Regul Integr Comp Physiol 2004; 286: R584–R590
   PubMedGoogle Scholar
• Morilak DA, Frazer A. Antidepressants and brain monoaminergic systems: A dimensional approach to understanding their behavioural effects in depression and anxiety disorders. Int J Neuropsychopharmacol 2004; 7: 193–218
   PubMed Web of Science ®Google Scholar
• Morris MJ, Na ES, Grippo AJ, Johnson AK. The effects of deoxycorticosterone-induced sodium appetite on hedonic behaviors in the rat. Behav Neurosci 2006; 120: 571–579
   PubMedGoogle Scholar
• Mortara A, La Rovere MT, Pinna GD, Prpa A, Maestri R, Febo O, Pozzoli M, Opasich C, Tavazzi L. Arterial baroreflex modulation of heart rate in chronic heart failure: Clinical and hemodynamic correlates and prognostic implications. Circulation 1997; 96: 3450–3458
   PubMed Web of Science ®Google Scholar
• Mössner R, Mikova O, Koutsilieri E, Saoud M, Ehlis AC, Müller N, Fallgatter AJ, Riederer P. Consensus paper of the WFSBP Task Force on Biological Markers: Biological markers in depression. World J Biol Psychiatry 2007; 8: 141–174
   PubMed Web of Science ®Google Scholar
• Murck H, Held K, Ziegenbein M, Künzel H, Koch K, Steiger A. The renin-angiotensin-aldosterone system in patients with depression compared to controls - a sleep endocrine study. BMC Psychiatry 2003; 3: 15–23
   PubMed Web of Science ®Google Scholar
• Murphy DL, Aulakh C, Mazzola-Pomietto P, Briggs NC. Neuroendocrine responses to serotonergic agonists as indices of the functional status of central serotonin neurotransmission in humans: A preliminary comparative analysis of neuroendocrine endpoints versus other endpoint measures. Behav Brain Res 1996; 73: 209–214
   PubMedGoogle Scholar
• Murray CJL, Lopez AD. The global burden of disease: A comprehensive assessment of mortality and disability from diseases, injuries, and risk factors in 1990 and projected to 2020. Harvard University Press, Cambridge 1996
   Google Scholar
• Muscat R, Papp M, Willner P. Antidepressant-like effects of dopamine agonist in an animal model of depression. Biol Psychiatry 1992; 31: 937–946
   PubMedGoogle Scholar
• Musselman DL, Evans DL, Nemeroff CB. The relationship of depression to cardiovascular disease. Arch Gen Psychiatry 1998; 55: 580–592
   PubMed Web of Science ®Google Scholar
• Nathan CF. Secretory products of macrophages. J Clin Invest 1987; 79: 319–327
   PubMed Web of Science ®Google Scholar
• National Institute of Mental Health. Depression can break your heart. National Institutes of Health, Bethesda 2001
   Google Scholar
• Nemeroff CB, Musselman DL, Evans DL. Depression and cardiac disease. Depress Anxiety 1998; 8(Suppl. 1)71–79
   Google Scholar
• Niiranen A, Laaksonen R, Iivanainen M, Mattson K, Fäkkilä M, Cantell K. Behavioral assessment of patients treated with alpha-interferon. Acta Psychiatr Scand 1988; 78: 622–626
   PubMed Web of Science ®Google Scholar
• Nosjean A, Franc B, Laguzzi R. Increased sympathetic nerve discharge without alteration in the sympathetic baroreflex response by serotonin3 receptor stimulation in the nucleus tractus solitarius of the rat. Neurosci Lett 1995; 186: 41–44
   PubMed Web of Science ®Google Scholar
• Overstreet DH, Commissaris RC, De La Garza R, II, File SE, Knapp DJ, Seiden LS. Involvement of 5-HT1A receptors in animal tests of anxiety and depression: Evidence from genetic models. Stress 2003; 6: 101–110
   PubMed Web of Science ®Google Scholar
• Owens MJ, Nemeroff CB. Role of serotonin in the pathophysiology of depression: Focus on the serotonin transporter. Clin Chem 1994; 40: 288–295
   PubMed Web of Science ®Google Scholar
• Palatini P, Julius S. Association of tachycardia with morbidity and mortality: Pathophysiological considerations. J Hum Hypertens 1997; 11(Suppl. 1)S19–S27
   PubMedGoogle Scholar
• Paluska SA, Schwenk TL. Physical activity and mental health: Current concepts. Sports Med 2000; 29: 167–180
   PubMed Web of Science ®Google Scholar
• Pandey GN, Pandey SC, Janicak PG, Marks RC, Davis JM. Platelet serotonin-2 receptor binding sites in depression and suicide. Biol Psychiatry 1990; 28: 215–222
   PubMed Web of Science ®Google Scholar
• Partarca R, Fletcher MA, Klimas NG. Immunological correlates of chronic fatigue syndrome. Chronic fatigue and related immune deficiency syndromes, PJ Goodnick, NG Klimas. American Psychiatric Press, Inc, Washington, DC 1993; 1–21
   Google Scholar
• Pelloux Y, Hagues G, Costentin J, Duterte-Boucher D. Helplessness in the tail suspension test is associated with an increase in ethanol intake and its rewarding effect in female mice. Alcoholism: Clin Exp Res 2005; 29: 378–388
   PubMedGoogle Scholar
• Penninx BWJH, Beekman ATF, Honig A, Deeg DJH, Schoevers RA, van Eijk JTM, van Tilburg W. Depression and cardiac mortality: Results from a community-based longitudinal study. Arch Gen Psychiatry 2001; 58: 221–227
   PubMed Web of Science ®Google Scholar
• Perski A, Osuchowski K, Andersson L, Sanden A, Feleke E, Anderson G. Intensive rehabilitation of emotionally distressed patients after coronary by-pass grafting. J Int Med 1999; 246: 253–263
   PubMedGoogle Scholar
• Pitt B, Zannad F, Remme WJ, Cody R, Castaigne A, Perez A, Palensky J, Wittes J. The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized aldactone evaluation study investigators. N Engl J Med 1999; 341: 709–717
   PubMed Web of Science ®Google Scholar
• Pitzalis MV, Iacoviello M, Todarello O, Fioretti A, Guida P, Massari F, Mastropasqua F, Russo GD, Rizzon P. Depression but not anxiety influences the autonomic control of heart rate after myocardial infarction. Am Heart J 2001; 141: 765–771
   PubMed Web of Science ®Google Scholar
• Pollak Y, Yirmiya R. Cytokine-induced changes in mood and behaviour: Implications for ‘depression due to a general medical condition’, immunotherapy and antidepressive treatment. Int J Neuropsychopharmacol 2002; 5: 389–399
   PubMed Web of Science ®Google Scholar
• Puffer JC, McShane JM. Depression and chronic fatigue in athletes. Clin Sports Med 1992; 11: 327–338
   PubMed Web of Science ®Google Scholar
• Raadsheer FC, van Heerikhuize JJ, Lucassen PJ, Hoogendijk WJG, Tilders FJH, Swaab DF. Corticotropin-releasing hormone mRNA levels in the paraventricular nucleus of patients with Alzheimer's disease and depression. Am J Psychiatry 1995; 152: 1372–1376
   PubMed Web of Science ®Google Scholar
• Rechlin T, Weis M, Claus D. Heart rate variability in depressed patients and differential effects of paroxetine and amitriptyline on cardiovascular autonomic functions. Pharmacopsychiatry 1994a; 27: 124–128
   PubMed Web of Science ®Google Scholar
• Rechlin T, Weis M, Spitzer A, Kaschka WP. Are affective disorders associated with alterations of heart rate variability?. J Affect Disord 1994b; 32: 271–275
   PubMed Web of Science ®Google Scholar
• Ressler KJ, Nemeroff CB. Role of serotonergic and noradrenergic systems in the pathophysiology of depression and anxiety disorders. Depress Anxiety 2000; 12(Suppl. 1)2–19
   PubMed Web of Science ®Google Scholar
• Rieckmann N, Kronish IM, Haas D, Gerin W, Chaplin WF, Burg MM, Vorchheimer D, Davidson KW. Persistent depressive symptoms lower aspirin adherence after acute coronary syndromes. Am Heart J 2006; 152: 922–927
   PubMedGoogle Scholar
• Rissanen V, Romo M, Siltanen P. Premonitory symptoms and stress factors preceding sudden death from ischaemic heart disease. Acta Med Scand 1978; 204: 389–396
   PubMedGoogle Scholar
• Roose SP, Glassman AH, Attia E, Woodring S, Giardina EGV, Bigger JT, Jr. Cardiovascular effects of fluoxetine in depressed patients with heart disease. Am J Psychiatry 1998a; 155: 660–665
   PubMed Web of Science ®Google Scholar
• Roose SP, Laghrissi-Thode F, Kennedy JS, Nelson JC, Bigger JT, Jr, Pollock BG, Gaffney A, Narayan M, Finkel MS, McCafferty J, Gergel I. Comparison of paroxetine and nortriptyline in depressed patients with ischemic heart disease. JAMA 1998b; 279: 287–291
   PubMed Web of Science ®Google Scholar
• Rossi J, Bayram M, Udelson JE, Lloyd-Jones D, Adams KF, O'Connor CM, Stough WG, Ouyang J, Shin DD, Orlandi C, Gheorghiade M. Improvement in hyponatremia during hospitalization for worsening heart failure is associated with improved outcomes: Insights from the Acute and Chronic Therapeutic Impact of a Vasopressin Antagonist in Chronic Heart Failure (ACTIV in CHF) trial. Acute Card Care 2007; 9: 82–86
   PubMedGoogle Scholar
• Roth BL. Multiple serotonin receptors: Clinical and experimental aspects. Ann Clin Psychiatry 1994; 6: 67–78
   PubMedGoogle Scholar
• Rothwell NJ, Hopkins SJ. Cytokines and the nervous system II: Actions and mechanisms of action. Trends Neurosci 1995; 18: 130–136
   PubMed Web of Science ®Google Scholar
• Roy A, Guthrie S, Pickar D, Linnoila M. Plasma norepinephrine responses to cold challenge in depressed patients and normal controls. Psychiatry Res 1987; 21: 161–168
   PubMedGoogle Scholar
• Rudisch B, Nemeroff CB. Epidemiology of comorbid coronary artery disease and depression. Biol Psychiatry 2003; 54: 227–240
   PubMed Web of Science ®Google Scholar
• Ryan C, Hollenberg M, Harvey DB, Gwynn R. Impaired parasympathetic responses in patients after myocardial infarction. Am J Cardiol 1976; 37: 1013–1018
   PubMed Web of Science ®Google Scholar
• Sanders BJ, Lawler JE. The borderline hypertensive rat (BHR) as a model for environmentally-induced hypertension: A review and update. Neurosci Biobehav Rev 1992; 16: 207–217
   PubMed Web of Science ®Google Scholar
• Sauer WH, Berlin JA, Kimmel SE. Effect of antidepressants and their relative affinity for the serotonin transporter on the risk of myocardial infarction. Circulation 2003; 108: 32–36
   PubMed Web of Science ®Google Scholar
• Schleifer SJ, Macari-Hinson MM, Coyle DA, Slater WR, Kahn M, Gorlin R, Zucker HD. The nature and course of depression following myocardial infarction. Arch Int Med 1989; 149: 1785–1789
   PubMed Web of Science ®Google Scholar
• Schlitz JC, Sawchenko PE. Distinct brain vascular cell types manifest inducible cyclooxygenase expression as a function of the strength and nature of immune insults. J Neurosci 2002; 22: 5606–5618
   PubMedGoogle Scholar
• Schwartz PJ, Vanoli E, Stramba-Badiale M, De Ferrari GM, Billman GE, Foreman RD. Autonomic mechanisms and sudden death. New insights from analysis of baroreceptor reflexes in conscious dogs with and without a myocardial infarction. Circulation 1988; 78: 969–979
   PubMedGoogle Scholar
• Sgoifo A, De Boer SF, Buwalda B, Korte-Bouws G, Tuma J, Bohus B, Zaagsma J, Koolhaas JM. Vulnerability to arrhythmias during social stress in rats with different sympathovagal balance. Am J Physiol Heart Circ Physiol 1998; 275: H460–H466
   PubMed Web of Science ®Google Scholar
• Sgoifo A, Pozzato C, Costoli T, Manghi M, Stilli D, Ferrari PF, Ceresini G, Musso E. Cardiac autonomic responses to intermittent social conflict in rats. Physiol Behav 2001; 73: 343–349
   PubMedGoogle Scholar
• Singh M, Johnson AK. Depression- and anxiety-related behaviors in transgenic mice overexpressing the RNA editing enzyme ADAR2. 2007, Program No. 907.16. 2007 Neuroscience Meeting Planner. SanDiego, CA: Society for Neuroscience Online
   Google Scholar
• Sirinathsinghji DJ, Rees LH, Rivier J, Vale W. Corticotropin-releasing factor is a potent inhibitor of sexual receptivity in the female rat. Nature 1983; 305: 232–235
   PubMedGoogle Scholar
• Smith RS. The macrophage theory of depression. Med Hypotheses 1991; 35: 298–306
   PubMed Web of Science ®Google Scholar
• Sole MJ, Versteeg DH, de Kloet ER, Hussain N, Lixfeld W. The identification of specific serotonergic nuclei inhibited by cardiac vagal afferents during acute myocardial ischemia in the rat. Brain Res 1983; 265: 55–61
   PubMedGoogle Scholar
• Spriggs DR, Sherman ML, Michie H, Arthor KA, Imamura K, Wilmore D, Frie E, Kufe DW. Recombinant human tumor necrosis factor administered as a 24-h intravenous infusion. A phase 1 and pharmacology study. J Natl Cancer Inst 1988; 80: 1039–1044
   PubMed Web of Science ®Google Scholar
• Stambor Z. Stressed out nation. Monitor on Psychology 2006; 37: 28–29
   Google Scholar
• Stenfors C, Ross SB. Evidence for involvement of 5-hydroxytryptamine(1B) autoreceptors in the enhancement of serotonin turnover in the mouse brain following repeated treatment with fluoxetine. Life Sci 2002; 71: 2867–2880
   PubMedGoogle Scholar
• Stier CT, Jr, Chander PN, Rocha R. Aldosterone as a mediator in cardiovascular injury. Cardiol Rev 2002; 10: 97–107
   PubMedGoogle Scholar
• Straus SE, Tosato G, Armstrong G, Lawley T, Preble OT, Henle W, Davey R, Pearson G, Epstein J, Brus I, Blaese RM. Persisting illness and fatigue in adults with evidence of Epstein-Barr virus infection. Ann Int Med 1985; 102: 7–16
   PubMed Web of Science ®Google Scholar
• Sullivan Hanley NR, Van de Kar LD. Serotonin and the neuroendocrine regulation of the hypothalamic–pituitary–adrenal axis in health and disease. Vitam Horm 2003; 66: 189–255
   PubMedGoogle Scholar
• Suls J, Bunde J. Anger, anxiety and depression as risk factors for cardiovascular disease: The problems and implications of overlapping affective dispositions. Psychol Bull 2005; 131: 260–300
   PubMed Web of Science ®Google Scholar
• Swaab DF, Bao A-M, Lucassen PJ. The stress system in the human brain in depression and neurodegeneration. Ageing Res Rev 2005; 4: 141–194
   PubMed Web of Science ®Google Scholar
• Swanson LW, Sawchenko PE. Paraventricular nucleus: A site for the integration of neuroendocrine and autonomic mechanisms. Neuroendocrinology 1980; 31: 410–417
   PubMed Web of Science ®Google Scholar
• Szegedy-Maszak M. Hearts and minds. US News and World Report 2003; 68–70, December 1
   PubMedGoogle Scholar
• Tapanainen JM, Thomsem PEB, Køber L, Torp-Pedersen C, Mäkikallio TH, Still A-M, Lindgren KS, Huikuri HV. Fractal analysis of heart rate variability and mortality after an acute myocardial infarction. Am J Cardiol 2002; 90: 347–352
   PubMed Web of Science ®Google Scholar
• Tobler I, Borbely AA, Schwyzer M, Fontana A. Interleukin-1 derived from astrocytes enhances slow wave activity in sleep EEG of the rat. Eur J Pharmacol 1984; 104: 191–192
   PubMed Web of Science ®Google Scholar
• Trimarco B, Ricciardelli B, Cuocolo A, Volpe M, De Luca N, Mele AF, Condorelli M. Effects of coronary occlusion on arterial baroreflex control of heart rate and vascular resistance. Am J Physiol Heart Circ Physiol 1987; 252: H749–H759
   Google Scholar
• Vaidya VA. Stress, depression, and hippocampal damage. J Biosci 2000; 25: 123–124
   PubMedGoogle Scholar
• Vaidya JG, Grippo AJ, Johnson AK, Watson D. A comparative developmental study of impulsivity in rats and humans: The role of reward sensitivity. Ann NY Acad Sci 2004; 1021: 395–398
   PubMedGoogle Scholar
• Van de Kar LD. Neuroendocrine aspects of the serotonergic hypothesis of depression. Neurosci Biobehav Rev 1989; 13: 237–246
   PubMed Web of Science ®Google Scholar
• Van de Kar LD, Blair ML. Forebrain pathways mediating stress-induced hormone secretion. Front Neuroendocrinol 1999; 20: 1–48
   PubMed Web of Science ®Google Scholar
• van Deist R, Appels A. Vital exhaustion and depression: A conceptual study. J Psychosom Res 1991; 35: 535–544
   PubMedGoogle Scholar
• Van der Kooy K, van Hout H, Marwijk H, Marten H, Stehouwer C, Beekman A. Depression and the risk for cardiovascular diseases: Systematic review and meta analysis. Int J Geriatr Psychiatry 2007; 22: 613–626
   PubMed Web of Science ®Google Scholar
• van Praag HM. Can stress cause depression?. Prog Neuropsychopharmacol Biol Psychiatry 2004; 28: 891–907
   PubMed Web of Science ®Google Scholar
• van Zwieten PA, Blauw GJ, van Brummelen P. Pathophysiological and pharmacotherapeutic aspects of serotonin and serotonergic drugs. Clin Physiol Biochem 1990; 8(Supp. 3)1–18
   PubMedGoogle Scholar
• Verrier RL, Lown B. Behavioral stress and cardiac arrhythmias. Annu Rev Physiol 1984; 46: 155–176
   PubMed Web of Science ®Google Scholar
• Watkins LL, Grossman P. Association of depressive symptoms with reduced baroreflex cardiac control in coronary artery disease. Am Heart J 1999; 137: 453–457
   PubMed Web of Science ®Google Scholar
• Watkins LL, Blumenthal JA, Carney RM. Association of anxiety with reduced baroreflex cardiac control in patients after acute myocardial infarction. Am Heart J 2002; 143: 460–466
   PubMedGoogle Scholar
• Watson D, Clark LA. Negative affectivity: The disposition to experience aversive emotional states. Psychol Bull 1984; 96: 465–490
   PubMed Web of Science ®Google Scholar
• Weber B, Lewicka S, Deuschle M, Colla M, Vecsei P, Heuser I. Increased diurnal plasma concentrations of cortisone in depressed patients. J Clin Endocrinol Metab 2000; 85: 1133–1136
   PubMedGoogle Scholar
• Wichers M, Maes M. The psychoneuroimmuno-pathophysiology of cytokine-induced depression in humans. Int J Neuropsychopharmacol 2002; 5: 375–388
   PubMed Web of Science ®Google Scholar
• Willner P. Dopaminergic mechanisms in depression and mania. Psychopharmacology: The fourth generation of progress, FE Bloom, DJ Kupfer. Raven Press, New York 1995; 921–931
   Google Scholar
• Willner P. The chronic mild stress procedure as an animal model of depression: Valid, reasonably reliable, and useful. Psychopharmacology 1997a; 134: 371–377
   Google Scholar
• Willner P. The mesolimbic dopamine system as a target for rapid antidepressant action. Int Clin Psychopharmacol 1997b; 12(Suppl. 3)S7–S14
   PubMedGoogle Scholar
• Willner P. Validity, reliability and utility of the chronic mild stress model of depression: A 10-year review and evaluation. Psychopharmacology 1997c; 134: 319–329
   PubMed Web of Science ®Google Scholar
• Willner P. Chronic mild stress (CMS) revisited: Consistency and behavioural-neurobiological concordance in the effects of CMS. Neuropsychobiology 2005; 52: 90–110
   PubMed Web of Science ®Google Scholar
• Willner P, Benton D, Brown E, Cheeta S, Davies G, Morgan J, Morgan M. “Depression” increases “craving” for sweet rewards in animal and human models of depression and craving. Psychopharmacology 1998; 136: 272–283
   PubMed Web of Science ®Google Scholar
• Wolk R. Central origin of decreased heart rate variability in patients with cardiovascular diseases. Med Hypotheses 1996; 46: 479–481
   PubMed Web of Science ®Google Scholar
• Wright JW, Krebs LT, Stobb JW, Harding JW. The angiotensin IV system: Functional implications. Front Neuroendocrinol 1995; 16: 23–52
   PubMed Web of Science ®Google Scholar
• Yeragani VK, Pohl R, Balon R, Ramesh C, Glitz D, Jung I, Sherwood P. Heart rate variability in patients with major depression. Psychiatry Res 1991; 37: 35–46
   PubMed Web of Science ®Google Scholar
• Zhang Y, Raap DK, Garcia F, Serres F, Ma Q, Battaglia G, Van de Kar LD. Long-term fluoxetine produces behavior anxiolytic effects without inhibiting neuroendocrine responses to conditioned stress in rats. Brain Res 2000; 855: 58–66
   PubMed Web of Science ®Google Scholar
• Zoeller RF, Jr. Physical activity: Depression, anxiety, physical activity, and cardiovascular disease: What's the connection?. Am J Lifestyle Med 2007; 1: 175–180
   Google Scholar
• Zorrilla EP, Luborsky L, McKay JR, Rosenthal R, Houldin A, Tax A, McCorkle R, Seligman DA, Schmidt K. The relationship of depression and stressors to immunological assays: A meta-analytic review. Brain Behav Immun 2001; 15: 199–226
   PubMed Web of Science ®Google Scholar